| Value | ₹72.66 Cr |
|---|
NSE filing, NSE: HESTERBIO. Summary written from the filing by ALFA Finder's alert engine.
Hester Biosciences Ltd: key numbers
- Share price
- ₹2,407.30
- Market cap
- ₹2,048 Cr
- Revenue (annual)
- ₹332.6 Cr
- Net profit (annual)
- ₹55.64 Cr
- P/E (TTM)
- 14.4×Sector 42.0×
- Promoter holding
- 44.28%-9.45% QoQ
- FII holding
- 0.30%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hester Biosciences Ltd
All →Hester Biosciences Q2 FY27 Results: Net Profit ₹20.6 Cr, Up 44.1% YoY
Hester Biosciences Ltd reported revenue from operations of ₹97.9 Cr (+37.9% YoY) and net profit of ₹20.6 Cr (+44.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹20.6 Cr · +44.1% YoY
Hester Biosciences Board Meeting Date
Hester Biosciences scheduled its Board of Directors meeting for 5 November 2026 to review unaudited H1 FY27 results. No decisions or figures are reported yet.
Hester Biosciences Management Change
Hester Biosciences disclosed Independent Director Mr. Ameetkumar Desai ceased his role on 27 October 2026 upon completing his first tenure. He opted not to seek re-appointment.
Hester Biosciences Other Announcement
Hester Biosciences reported shareholding data for the quarter ending September 2026. Two promoters were reclassified as public shareholders, reducing the promoter holding.
Hester Biosciences Capacity Expansion: ₹1.05 Cr Investment
Hester Biosciences' board approved a ₹1.05 Cr stake in SLYCE AGRI WORLD LLP for captive solar power generation. The PPA secures captive electricity supply to the company.
- Value
- ₹1.05 Cr
- Execution
- six months
Hester Biosciences Promoter Reclassification
Hester Biosciences Limited received shareholder approval to reclassify Mr. Ravin Gandhi and Ms. Bela Gandhi from the 'Promoter' category to the 'Public' category.
Other results update announcements
All →Cello World Results Update
Cello World's Q2 FY27 revenue rose 7.8% to Rs.633 crore, while PAT fell 10.3%. This investor press release highlights results, not the full statement.
Ashoka Buildcon Results Update
Ashoka Buildcon's Q2 FY27 press release shows standalone PAT of Rs.37.9 crore, down from Rs.139.2 crore. Order book stands at Rs.15,964 crore.
Arrow Greentech Results Update
Arrow Greentech (BSE 516064) issued a press release on unaudited half-year results ended 30 September 2026. Revenue, EBITDA and profit grew strongly year-on-year.
Avadh Sugar & Energy Results Update
Avadh Sugar & Energy reported Q2 FY27 revenue of Rs.652 Cr and PAT of Rs.10 Cr. H1 FY27 EBITDA rose to Rs.80 Cr from Rs.49 Cr.
Inventurus Knowledge Solutions Results Update
IKS Health reported strong Q2 FY27 revenue and EBITDA growth year-on-year, with TruBridge integration adding scale. The release also highlighted new US healthcare customer wins.
Gokaldas Exports Results Update
Gokaldas Exports issued a press release on unaudited Q2 and H1 FY27 results, reporting consolidated total income of ₹1,135 crore (up 13% YoY) and EBITDA of ₹127 crore. The release includes a P&L highlights table with Total Income, EBITDA and PAT rows.